MITNACHT-KRAUS; Rita

Patent Applications and Registrations

Patent applications and USPTO patent grants for MITNACHT-KRAUS; Rita.The latest application filed is for "antibodies useful in cancer diagnosis".

Company Profile

7.12.20

MITNACHT-KRAUS; Rita - Friedberg DE
Mitnacht-Kraus; Rita - Bad Vilbel N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies Useful In Cancer Diagnosis App 20220162302 - MITNACHT-KRAUS; Rita ; et al.	2022-05-26
Antibodies useful in cancer diagnosis Grant 11,279,757 - Mitnacht-Kraus , et al. March 22, 2	2022-03-22
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Grant 10,946,069 - Sahin , et al. March 16, 2	2021-03-16
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20210023177 - Sahin; Ugur ; et al.	2021-01-28
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20200390887 - Sahin; Ugur ; et al.	2020-12-17
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Grant 10,813,996 - Sahin , et al. October 27, 2	2020-10-27
Antibodies Useful In Cancer Diagnosis App 20200199221 - MITNACHT-KRAUS; Rita ; et al.	2020-06-25
Monoclonal anti-GT 468 antibodies for treatment of cancer Grant 10,596,256 - Sahin , et al.	2020-03-24
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20190298803 - Sahin; Ugur ; et al.	2019-10-03
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Grant 10,314,890 - Sahin , et al.	2019-06-11
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20180326059 - Sahin; Ugur ; et al.	2018-11-15
Antibodies Against Claudin 18.2 Useful In Cancer Diagnosis App 20180319891 - Sahin; Ugur ; et al.	2018-11-08
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20180258180 - Sahin; Ugur ; et al.	2018-09-13
Antibodies against claudin 18.2 useful in cancer diagnosis Grant 10,053,512 - Sahin , et al. August 21, 2	2018-08-21
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Grant 10,022,444 - Sahin , et al. July 17, 2	2018-07-17
Drug Conjugates Comprising Antibodies Against Claudin 18.2 App 20180117174 - Sahin; Ugur ; et al.	2018-05-03
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20180000900 - Sahin; Ugur ; et al.	2018-01-04
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinoma Grant 9,770,487 - Sahin , et al. September 26, 2	2017-09-26
Antibodies against Claudin 18.2 useful in cancer diagnosis Grant 9,512,232 - Sahin , et al. December 6, 2	2016-12-06
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20160339101 - Sahin; Ugur ; et al.	2016-11-24
Antibodies Against Claudin 18.2 Useful In Cancer Diagnosis App 20160333109 - Sahin; Ugur ; et al.	2016-11-17
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer Grant 9,433,675 - Sahin , et al. September 6, 2	2016-09-06
Monoclonal Antibodies For Treatment Of Cancer App 20160185873 - Sahin; Ugur ; et al.	2016-06-30
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20150374789 - Sahin; Ugur ; et al.	2015-12-31
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20150157711 - Sahin; Ugur ; et al.	2015-06-11
Antibodies Against Claudin 18.2 Useful in Cancer Diagnosis App 20150147763 - Sahin; Ugur ; et al.	2015-05-28
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer App 20150132253 - Sahin; Ugur ; et al.	2015-05-14
Monoclonal antibodies for treatment of cancer Grant 8,946,388 - Sahin , et al. February 3, 2	2015-02-03
Monoclonal Antibodies For Treatment Of Cancer App 20130071325 - Sahin; Ugur ; et al.	2013-03-21
Monoclonal Antibodies For Treatment Of Cancer App 20110223182 - Sahin; Ugur ; et al.	2011-09-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.